신경혈관용 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Neurovascular Devices Market size is expected to reach USD 7.93 Billion in 2034 from USD 3.55 Billion (2025) growing at a CAGR of 9.34% during 2026-2034.

The global neurovascular devices market has experienced significant growth due to the increasing prevalence of neurological disorders and cerebrovascular diseases. Neurovascular devices are used in the diagnosis and treatment of conditions such as brain aneurysms, strokes, and arteriovenous malformations. These devices play a crucial role in minimally invasive procedures that improve patient outcomes and reduce surgical risks.

Key drivers of the neurovascular devices market include the rising incidence of stroke and the growing demand for advanced treatment technologies. Healthcare providers are increasingly adopting minimally invasive endovascular procedures that utilize specialized neurovascular devices. Technological advancements in imaging systems and catheter-based treatment methods are also improving the effectiveness and safety of these procedures.

Looking ahead, the neurovascular devices market is expected to expand as medical technology continues to evolve. Increased investment in neurological research and improved diagnostic capabilities will support market growth. The development of innovative treatment devices and expanding healthcare access in developing regions will further strengthen demand. As awareness of neurological health increases, neurovascular devices will play an increasingly important role in modern medical care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Stenting Systems
• Embolization Devices
• Neurothrombectomy Devices
• Support Devices

By Application

• Cerebral Aneurysms
• Ischemic Stroke
• Others

By End-User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• Medtronic, Penumbra, Stryker, Johnson and Johnson Services CERENOVUS, MicroPort Scientific Corporation, Acandis GmbH, MicroVention, NeuroVasc Technologies, Asahi Intecc Co Ltd, Perflow Medical Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROVASCULAR DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Stenting Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Embolization Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Neurothrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Support Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROVASCULAR DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cerebral Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ischemic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROVASCULAR DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROVASCULAR DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROVASCULAR DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Penumbra
  • 9.2.3 Stryker
  • 9.2.4 Johnson And Johnson Services (CERENOVUS)
  • 9.2.5 MicroPort Scientific Corporation
  • 9.2.6 Acandis GmbH
  • 9.2.7 MicroVention
  • 9.2.8 NeuroVasc Technologies
  • 9.2.9 Asahi Intecc Co. Ltd
  • 9.2.10 Perflow Medical Ltd